全文获取类型
收费全文 | 3996篇 |
免费 | 231篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 255篇 |
妇产科学 | 43篇 |
基础医学 | 508篇 |
口腔科学 | 94篇 |
临床医学 | 286篇 |
内科学 | 813篇 |
皮肤病学 | 37篇 |
神经病学 | 257篇 |
特种医学 | 185篇 |
外科学 | 449篇 |
综合类 | 76篇 |
一般理论 | 1篇 |
预防医学 | 257篇 |
眼科学 | 394篇 |
药学 | 279篇 |
1篇 | |
中国医学 | 15篇 |
肿瘤学 | 255篇 |
出版年
2023年 | 32篇 |
2022年 | 62篇 |
2021年 | 121篇 |
2020年 | 73篇 |
2019年 | 84篇 |
2018年 | 98篇 |
2017年 | 69篇 |
2016年 | 82篇 |
2015年 | 96篇 |
2014年 | 158篇 |
2013年 | 165篇 |
2012年 | 297篇 |
2011年 | 274篇 |
2010年 | 163篇 |
2009年 | 139篇 |
2008年 | 230篇 |
2007年 | 252篇 |
2006年 | 226篇 |
2005年 | 213篇 |
2004年 | 204篇 |
2003年 | 135篇 |
2002年 | 123篇 |
2001年 | 102篇 |
2000年 | 87篇 |
1999年 | 76篇 |
1998年 | 28篇 |
1997年 | 23篇 |
1996年 | 17篇 |
1995年 | 22篇 |
1994年 | 14篇 |
1993年 | 15篇 |
1992年 | 34篇 |
1991年 | 38篇 |
1990年 | 42篇 |
1989年 | 45篇 |
1988年 | 28篇 |
1987年 | 33篇 |
1986年 | 32篇 |
1985年 | 27篇 |
1984年 | 21篇 |
1983年 | 19篇 |
1982年 | 14篇 |
1981年 | 22篇 |
1980年 | 13篇 |
1979年 | 32篇 |
1977年 | 16篇 |
1975年 | 17篇 |
1973年 | 13篇 |
1972年 | 13篇 |
1970年 | 13篇 |
排序方式: 共有4238条查询结果,搜索用时 31 毫秒
61.
Abhijit Chougule Shreya Srivastava Sidharth Totadri Radhika Srinivasan Amita Trehan 《Diagnostic cytopathology》2015,43(12):1000-1002
Multinucleated giant cells of osteoclastic type are known to occur in nodal and extranodal lesions of Langerhans cell histiocytosis (LCH). These giant cells are thought to be derived from phagocytic histiocytes, which correlate with the degree of necrosis in LCH lesions. Emperipolesis commonly seen in Rosai–Dorfman disease is a distinct phenomenon characterized by intact phagocytosed cells in an intracytoplasmic vacuole protected from proteolytic digestion. We present a case of emperipolesis of inflammatory cells especially of eosinophils by multinucleated giant cells of Langhans type in a lymph node involved by LCH—a finding that has not been described previously in the literature. Diagn. Cytopathol. 2015;43:1000–1002. © 2015 Wiley Periodicals, Inc. 相似文献
62.
63.
Srinivasan Jayaraman 《Journal of Indian Prosthodontic Society》2015,15(2):179-182
The failure of dental implant can occurs at the preoperative planning stage, at the surgical stage, and at the postoperative stage. The success of this treatment can be increased if the clinical implant practice guidelines are prepared based on the recommendations from the highest level of research evidence (i.e.,) from systematic review of randomized controlled trials (RCTs) with meta-analysis. The Cochrane reviews of interventions are basically systematic reviews of RCTs with meta-analysis but follow a systematic methodological approach following the guidelines from Cochrane handbook for Systematic Reviews of Intervention. They give the current best evidence as they are updated every 2 years which is being the minimum period for an update. This evidence summary recommends the use of antibiotics, single dose of 2 g of amoxicillin 1 h prior to implant surgery to prevent implant failure, based on the body of evidence from the Cochrane review that was first published in 2003, 2008, and then updated twice in 2010 and 2013. The included studies are not from our population for the research question asked in this updated Cochrane review; hence, the need to do primary research in our population to support the available evidence is mandatory.Key Words: Antibiotics, evidence summary, implant placement 相似文献
64.
Srinivasan Sakthivel Andrea Zatkova Martina Nemethova Milan Surovy Ludevit Kadasi Madurai P. Saravanan 《Annals of human genetics》2014,78(3):155-164
Alkaptonuria (AKU) is an autosomal recessive disorder; caused by the mutations in the homogentisate 1, 2‐dioxygenase (HGD) gene located on Chromosome 3q13.33. AKU is a rare disorder with an incidence of 1: 250,000 to 1: 1,000,000, but Slovakia and the Dominican Republic have a relatively higher incidence of 1: 19,000. Our study focused on studying the frequency of AKU and identification of HGD gene mutations in nomads. HGD gene sequencing was used to identify the mutations in alkaptonurics. For the past four years, from subjects suspected to be clinically affected, we found 16 positive cases among a randomly selected cohort of 41 Indian nomads (Narikuravar) settled in the specific area of Tamil Nadu, India. HGD gene mutation analysis showed that 11 of these patients carry the same homozygous splicing mutation c.87 + 1G > A; in five cases, this mutation was found to be heterozygous, while the second AKU‐causing mutation was not identified in these patients. This result indicates that the founder effect and high degree of consanguineous marriages have contributed to AKU among nomads. Eleven positive samples were homozygous for a novel mutation c.87 + 1G > A, that abolishes an intron 2 donor splice site and most likely causes skipping of exon 2. The prevalence of AKU observed earlier seems to be highly increased in people of nomadic origin. 相似文献
65.
Kudrat M. Abdulkadyrov Galina N. Salogub Nuriet K. Khuazheva Matthew L. Sherman Abderrahmane Laadem Rachel Barger Robert Knight Shankar Srinivasan Evangelos Terpos 《British journal of haematology》2014,165(6):814-823
This phase IIa study evaluated the safety and tolerability of sotatercept, and its effects on bone metabolism and haematopoiesis in newly diagnosed and relapsed multiple myeloma (MM) patients. Patients were randomized (4:1) to receive four 28‐d cycles of sotatercept (0·1, 0·3, or 0·5 mg/kg) or placebo. Patients also received six cycles of combination oral melphalan, prednisolone, and thalidomide (MPT). Thirty patients were enrolled; six received placebo and 24 received sotatercept. Overall, 25% of patients received all four sotatercept doses; 71% of sotatercept‐treated patients had ≥1 dose interruption mainly due to increases in haemoglobin levels. Grade ≥3 adverse events (AEs) were reported in 17% of patients receiving placebo and 58% receiving sotatercept. Grade 4 AEs in sotatercept‐treated patients were neutropenia, granulocytopenia, and atrial fibrillation (one patient each). In patients without bisphosphonate use, anabolic improvements in bone mineral density and in bone formation relative to placebo occurred, whereas bone resorption was minimally affected. Increases in haemoglobin levels, versus baseline, and the duration of the increases, were higher in the sotatercept‐treated patients, with a trend suggesting a dose‐related effect. Multiple doses of sotatercept plus MPT appear to be safe and generally well‐tolerated in MM patients. 相似文献
66.
67.
68.
69.
Nakhleh N Francis R Giese RA Tian X Li Y Zariwala MA Yagi H Khalifa O Kureshi S Chatterjee B Sabol SL Swisher M Connelly PS Daniels MP Srinivasan A Kuehl K Kravitz N Burns K Sami I Omran H Barmada M Olivier K Chawla KK Leigh M Jonas R Knowles M Leatherbury L Lo CW 《Circulation》2012,125(18):2232-2242